FDA Warning Letter — BP

Case 544312 — FEI 3014137813

The FDA took a Warning Letter action against BP on Jan 11, 2018 (Mineral Point, WI). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Jan 11, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Mineral Point, WI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.